By playing a critical role in activating signaling cascades that support melanoma cell survival and self-renewing capacity, as well as, their metastases, CD271 unveils itself as a potentially powerful therapeutic target for the treatment of metastatic disease. This evidence concerns the gene NGFR and metastatic neoplasm.